InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,299.13
(
0.59%
)
US TECH 100
18,299.60
(
0.84%
)
Dow Jones
39,062.70
(
-0.01%
)
Brent Oil
81.92
(
0.74%
)
Bitcoin
68,964.42
(
1.53%
)
Post# of 1236
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Vision and Value

Send PM Follow Ignore
Followers 2
Posts 24
Boards Moderated 0
Alias Born 01/08/2020

Vision and Value

Re: None

Wednesday, 03/08/2023 10:51:20 AM

Wednesday, March 08, 2023 10:51:20 AM

Post# of 1236
New article out on Zerohedge highlighting ProLectin. Drug is pretty promising. Especially since the ritonavir in Paxlovid means that Paxlovid won't be a good idea for long COVID. ProLectin is the best approach for Long COVID I've seen. But also potentially the best antiviral for acute COVID too, as explained in the article.

https://www.zerohedge.com/news/2023-03-07/sick-jabs-and-rebounds-breakthrough-antiviral-flushes-out-multiple-viruses
Bullish
Bullish
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent BIXT News
More BIXT News
InvestorsHub NewsWire

Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM

Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM

"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

Start posting your company's news
Only $200 per official company press release!